Health Condition 1: null- Knee Osteoarthritis
Conditions
Interventions
Intervention1: Ossigen Capsules: Each Ossigen Capsule Contains :
Kandvel - 50 mg
Arjuna - 50 mg
Kukkutandtwak Bhasma - 150 mg
Maida Lakdi - 50 mg
Two Capsules, Twice a Day (2 B.I.D)Orally for a conti
Sponsors
SG Phyto Pharma Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: • Male and Female (of and between 18 and 60 years of age) subjects suffering from Knee Osteoarthritis. • Be informed of the nature of the study and will give written informed consent. • Able to communicate well with the investigator, to understand and comply with the requirements of the study. • Patients who are suffering from Osteoarthritis
Exclusion criteria
Exclusion criteria: • Individuals who usually use an ambulation aid to walk such as a cane, crutch, walker or wheel chair. • Amputation of foot or previous major trauma to foot that would raise concerns about whether an insert might worsen foot pain. Persons with foot lesions such as sores or ulcers in which redistributing load in the foot might be dangerous, will be excluded. • Past history of deep venous thrombosis. • Pain emanating more from back or hip than from knee • Low pain score on WOMAC (less than or equal to 24) • Individuals who have received corticosteroid injections in the month prior to starting the trial. Individuals who had bilateral total knee replacements (TKR) or planning for TKR in next 6 months for affected knee. • Known other causes of arthritis including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), gout, psoriatic arthritis, pseudo gout. • Individuals with BMI > 30 kg/m2 • Any disease or condition which might compromise the hematopoietic, renal, endocrine, pulmonary, central nervous, cardiovascular, immunological, dermatological, gastrointestinal or any other body system. • History of autoimmune disorders â?? lupus erythematosis (SLE) or immunodeficiency diseases, including HIV. • Subjects using NSAIDS. • Presence of clinically significant abnormal laboratory results during screening. • Pregnancy or not using appropriate means of contraception • Use of any recreational drugs or a history of drug addiction. • Patient not willing to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean Reduction of pain from baseline, measured on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), VAS (Visual Analogue Scale).Timepoint: 105 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ To determine the Mean time for the process of Healing & Degree of Movement. â?¢ Measurement of decrease in swelling by physical examination and X-ray. Timepoint: 105 Days | — |
Countries
India
Contacts
Public ContactSrinivas Lanka
Sanjeevani Bio Services Pvt Ltd
Outcome results
None listed